Issued Patents 2023
Showing 1–8 of 8 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11826409 | Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers | Andrea Mahr, Toni Weinschenk, Oliver Schoor, Jens Fritsche, Harpreet Singh +2 more | 2023-11-28 |
| 11786583 | Peptides and combination of peptides for use in immunotherapy against Hepatocellular carcinoma (HCC) and other cancers | Toni Weinschenk, Andrea Mahr, Jens Fritsche, Anita Wiebe, Sarah Kutscher | 2023-10-17 |
| 11786584 | Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers | Andrea Mahr, Toni Weinschenk, Oliver Schoor, Jens Fritsche, Harpreet Singh +2 more | 2023-10-17 |
| 11779638 | Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells | Toni Weinschenk, Andrea Mahr, Jens Fritsche, Anita Wiebe, Sarah Kutscher | 2023-10-10 |
| 11679147 | Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells | Toni Weinschenk, Andrea Mahr, Jens Fritsche, Anita Wiebe, Sarah Kutscher | 2023-06-20 |
| 11672848 | Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells | Toni Weinschenk, Andrea Mahr, Jens Fritsche, Anita Wiebe, Sarah Kutscher | 2023-06-13 |
| 11576956 | Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers | Toni Weinschenk, Andrea Mahr, Jens Fritsche, Anita Wiebe, Sarah Kutscher | 2023-02-14 |
| 11559573 | Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells | Toni Weinschenk, Andrea Mahr, Jens Fritsche, Anita Wiebe, Sarah Kutscher | 2023-01-24 |